AllianceBernstein’s Celgene Corp CELG Stock Holding History

AllianceBernstein’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200,000	Closed	-$19.9M	–	3206
2019 Q3	$19.9M	Buy	+200,000	New	+$19M	0.01%	794
2019 Q2	–	Sell	-130,000	Closed	-$12.3M	–	3267
2019 Q1	$12.3M	Buy	+130,000	New	+$11.4M	0.01%	962

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

AllianceBernstein's CELG Position: Q4 2019 in Review

AllianceBernstein sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,956,087 shares — an estimated $194M sold.

AllianceBernstein first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $571M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

AllianceBernstein reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
AllianceBernstein sold 1,956,087 Celgene Corp shares in Q4 2019, an estimated $194M.
AllianceBernstein first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
AllianceBernstein's Celgene Corp position peaked at $571M in Q4 2013.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.